Europe’s Gold Standard Event for Pharma & Biotech Patent Litigation
C5’s Pharma & Biotech Patent Litigation in Europe Forum brings together top litigators, government, industry associations and in-house counsel to explore the latest legal and regulatory developments impacting the life sciences industry.
Attend and gain practical insights on the UPC’s evolving jurisprudence, international and national European patent litigation strategies, and the EU’s regulatory changes.
Join us for two days of engagement with the European life sciences patent bar and shape the future of pharma and biotech litigation.
View AgendaConference Co-Chairs
Penny Gilbert
Partner
Powell Gilbert
Dr. Rose Hughes, PhD, EPA
European Patent Attorney
Evolve IP
Judiciary
Emmanuel Gougé
Judge (Legally Qualified)
UPC, Court of Appeal
Dr. Florian Schweyer
Judge
7th Civil Chamber, Munich Regional Court
Government and Patent Offices
Dr. Martijn de Lange
Patent Examiner
Netherlands Patent Office
Elodie Ferraty
Patent Examiner
INPI (French Patent Office)
Rieke Kaup
Case Handler
DG Comp, European Commission
Dr. Stefanie Vukovic
Patent Examiner
DPMA (German Patent Office)
Dr. Fergal Brady
Patent Examiner
Intellectual Property Office of Ireland
Patrick Purcell
Senior Patent Examiner
UK Intellectual Property Office
Featured Speakers
Brigitte Carion-Taravella, PhD
Principal Patent Counsel, Lead Biologics IP EU and EU Patent Policy
Sanofi (France)
Ruud van der Velden
Partner
Hogan Lovells LLP (the Netherlands)
Dr. Kai Rüting
Partner | UPC Representative
Vossius & Partner (Germany)
Dr. Cláudia Trabuco
Global Head of Competition Law
Gilead Sciences (Portugal)
Lucy Samuels
Partner
Gill Jennings & Every LLP (UK)
Sergio Napolitano
General Counsel & Director of External Relations
Medicines for Europe (Belgium)
Gain Insights, Global Perspectives and Develop Winning Strategies
Analyze emerging litigation trends at the UPC, the UPC Court of Appeal, and national courts
Demystify forum selection and parallel proceedings in the EU and the US
Navigate the evolving EU regulatory landscape and its impact on IP
Adapt to EU competition law enforcement trends and cadence
Redefine cross-border patent litigation strategy following the far-reaching BSH v Electrolux case
Respond to law-shaping decisions from the EPO and the EBA
Reconcile diverging standards for preliminary injunctions and the doctrine of equivalence
Who Should Attend
In-Housel Counsel and Executives from Pharmaceutical and Biotech Companies, including:
- Head of IP
- Head of Patent Litigation
- VP-Intellectual property
- Scientific Director
- Head of Legal / Legal Affairs
- Principal Patent Examiner
- Head of Global Strategy
- Director Innovation, IP and Portfolio Management
- R&D Patent manager
- Associate VP & Director of Technology Licensing & Commercialization
- Patent Counsel
Law firm attorneys with
practices in:
- Intellectual Property and Patent Law
- Life Sciences
- European Patent Law
- US Patent
“The combination of networking opportunities with people from various backgrounds. Concise overview over the most relevant topics.”
“Good networking opportunities with in-house Counsel and leading IP law firms. Hot topics, great speakers and convenient number of attendants.”
“Important subject matters to discuss presented by renowned specialists. An important conference to attend.”
Sponsors & Partners
Associate Sponsor
Conference Sponsor
Lanyards Sponsor
Media Partners
Sponsor Opportunities
With conferences in the United States, Europe, Asia Pacific, and Latin America, the C5 Group of Companies: American Conference Institute, the Canadian Institute, and C5 Group, provides a diverse portfolio of conferences, events and roundtables devoted to providing business intelligence to senior decision makers responding to challenges around the world.
For more information please contact:
Aaron Goldstein
Senior Business Development Manager
Email: [email protected]
